KR102305298B1 - 피리미딘 중간체의 제조 방법 - Google Patents
피리미딘 중간체의 제조 방법 Download PDFInfo
- Publication number
- KR102305298B1 KR102305298B1 KR1020167003201A KR20167003201A KR102305298B1 KR 102305298 B1 KR102305298 B1 KR 102305298B1 KR 1020167003201 A KR1020167003201 A KR 1020167003201A KR 20167003201 A KR20167003201 A KR 20167003201A KR 102305298 B1 KR102305298 B1 KR 102305298B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- ethylene glycol
- process according
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Detergent Compositions (AREA)
- Magnetic Heads (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Extraction Or Liquid Replacement (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Manufacturing Cores, Coils, And Magnets (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13176374.0 | 2013-07-12 | ||
| EP13176374 | 2013-07-12 | ||
| PCT/EP2014/064904 WO2015004265A1 (en) | 2013-07-12 | 2014-07-11 | Process for preparing a pyrimidine intermediate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20160030972A KR20160030972A (ko) | 2016-03-21 |
| KR102305298B1 true KR102305298B1 (ko) | 2021-09-27 |
Family
ID=48790244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020167003201A Expired - Fee Related KR102305298B1 (ko) | 2013-07-12 | 2014-07-11 | 피리미딘 중간체의 제조 방법 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9556125B2 (enExample) |
| EP (1) | EP3019479B1 (enExample) |
| JP (1) | JP6375374B2 (enExample) |
| KR (1) | KR102305298B1 (enExample) |
| CN (1) | CN105636940B (enExample) |
| AR (1) | AR096865A1 (enExample) |
| CA (1) | CA2915736C (enExample) |
| DK (1) | DK3019479T3 (enExample) |
| ES (1) | ES2636937T3 (enExample) |
| HR (1) | HRP20171166T1 (enExample) |
| HU (1) | HUE034071T2 (enExample) |
| IL (1) | IL243477B (enExample) |
| MX (1) | MX360768B (enExample) |
| PL (1) | PL3019479T3 (enExample) |
| PT (1) | PT3019479T (enExample) |
| TW (1) | TWI643848B (enExample) |
| WO (1) | WO2015004265A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA201605808B (en) | 2015-08-26 | 2017-08-30 | Cipla Ltd | Process for preparing an endothelin receptor antagonist |
| CN105461638A (zh) * | 2015-12-10 | 2016-04-06 | 合肥久诺医药科技有限公司 | 一种马西替坦晶型及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002053557A1 (en) | 2000-12-18 | 2002-07-11 | Actelion Pharmaceuticals Ltd | Novel sulfamides and their use as endothelin receptor antagonists |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103724281A (zh) * | 2013-12-03 | 2014-04-16 | 镇江圣安医药有限公司 | N-[5-（4-溴苯基）-6-[2-[（5-溴-2-嘧啶基）氧基]乙氧基]-4-嘧啶基]-n′-丙基磺酰胺的新型衍生物及其应用 |
| CN103819411A (zh) * | 2014-03-14 | 2014-05-28 | 成都克莱蒙医药科技有限公司 | 一种马西替坦中间体新的制备方法 |
-
2014
- 2014-07-10 AR ARP140102549A patent/AR096865A1/es active IP Right Grant
- 2014-07-11 CA CA2915736A patent/CA2915736C/en active Active
- 2014-07-11 KR KR1020167003201A patent/KR102305298B1/ko not_active Expired - Fee Related
- 2014-07-11 DK DK14737272.6T patent/DK3019479T3/en active
- 2014-07-11 US US14/904,657 patent/US9556125B2/en active Active
- 2014-07-11 CN CN201480039832.2A patent/CN105636940B/zh active Active
- 2014-07-11 TW TW103124052A patent/TWI643848B/zh not_active IP Right Cessation
- 2014-07-11 PT PT147372726T patent/PT3019479T/pt unknown
- 2014-07-11 EP EP14737272.6A patent/EP3019479B1/en active Active
- 2014-07-11 WO PCT/EP2014/064904 patent/WO2015004265A1/en not_active Ceased
- 2014-07-11 MX MX2016000386A patent/MX360768B/es active IP Right Grant
- 2014-07-11 ES ES14737272.6T patent/ES2636937T3/es active Active
- 2014-07-11 HR HRP20171166TT patent/HRP20171166T1/hr unknown
- 2014-07-11 JP JP2016524837A patent/JP6375374B2/ja active Active
- 2014-07-11 HU HUE14737272A patent/HUE034071T2/en unknown
- 2014-07-11 PL PL14737272T patent/PL3019479T3/pl unknown
-
2016
- 2016-01-06 IL IL243477A patent/IL243477B/en active IP Right Grant
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002053557A1 (en) | 2000-12-18 | 2002-07-11 | Actelion Pharmaceuticals Ltd | Novel sulfamides and their use as endothelin receptor antagonists |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3019479B1 (en) | 2017-05-10 |
| KR20160030972A (ko) | 2016-03-21 |
| US9556125B2 (en) | 2017-01-31 |
| JP2016525094A (ja) | 2016-08-22 |
| MX2016000386A (es) | 2016-04-29 |
| IL243477B (en) | 2018-06-28 |
| PL3019479T3 (pl) | 2017-10-31 |
| US20160145215A1 (en) | 2016-05-26 |
| TWI643848B (zh) | 2018-12-11 |
| HRP20171166T1 (hr) | 2017-10-06 |
| DK3019479T3 (en) | 2017-07-17 |
| CN105636940B (zh) | 2018-02-27 |
| WO2015004265A1 (en) | 2015-01-15 |
| MX360768B (es) | 2018-11-15 |
| CA2915736C (en) | 2021-07-27 |
| EP3019479A1 (en) | 2016-05-18 |
| AR096865A1 (es) | 2016-02-03 |
| ES2636937T3 (es) | 2017-10-10 |
| HUE034071T2 (en) | 2018-01-29 |
| CA2915736A1 (en) | 2015-01-15 |
| JP6375374B2 (ja) | 2018-08-15 |
| CN105636940A (zh) | 2016-06-01 |
| TW201536759A (zh) | 2015-10-01 |
| PT3019479T (pt) | 2017-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102406358B1 (ko) | 피리미딘 술파미드 유도체의 제조 방법 | |
| CA2900911C (en) | Preparation of pyrimidine intermediates useful for the manufacture of macitentan | |
| RU2567856C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ 5-ЗАМЕЩЕННЫХ-8-АЛКОКСИ[1,2,4]ТРИАЗОЛО[1,5-c]ПИРИМИДИН-2-АМИНОВ | |
| KR102305298B1 (ko) | 피리미딘 중간체의 제조 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| PA0302 | Request for accelerated examination |
St.27 status event code: A-1-2-D10-D16-exm-PA0302 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20240917 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20240917 |